Brevan Howard Capital Management’s Synopsys SNPS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.36M Buy
5,958
+2,957
+99% +$1.34M 0.02% 491
2025
Q4
$1.41M Buy
3,001
+2,106
+235% +$936K 0.02% 616
2025
Q3
$442K Sell
895
-3,516
-80% -$1.99M ﹤0.01% 1345
2025
Q2
$2.26M Buy
+4,411
New +$2.06M 0.01% 685
2024
Q4
Sell
-720
Closed -$365K 1397
2024
Q3
$365K Buy
+720
New +$386K ﹤0.01% 781
2024
Q1
Sell
-2,135
Closed -$1.1M 1329
2023
Q4
$1.1M Buy
+2,135
New +$1.09M 0.01% 212

Other funds holding SNPS

Brevan Howard Capital Management's SNPS Position: Q1 2026 in Review

Brevan Howard Capital Management increased its Synopsys (SNPS) stake by 99% in Q1 2026, buying an estimated $1.34M and bringing the position to 5,958 shares worth $2.36M. The position accounts for 0.02% of the portfolio, ranked #491.

Brevan Howard Capital Management first reported a position in SNPS in Q4 2023 and has held it in 6 quarters since. 1,390 funds tracked by Wall St. Rank hold SNPS as of Q1 2026.

  • Brevan Howard Capital Management held 5,958 shares of Synopsys worth $2.36M as of Q1 2026.
  • Brevan Howard Capital Management bought 2,957 Synopsys shares in Q1 2026, an estimated $1.34M.
  • Synopsys made up 0.02% of Brevan Howard Capital Management's portfolio in Q1 2026, its #491 holding.
  • Brevan Howard Capital Management first reported a position in Synopsys in Q4 2023 and has held it in 6 quarters since.
  • 1,390 funds tracked by Wall St. Rank held Synopsys as of Q1 2026.

Based on Brevan Howard Capital Management's 13F filing for Q1 2026, filed 15 May 2026.